▶ 調査レポート

世界の新型コロナウイルス感染症治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Covid-19 Treatments Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の新型コロナウイルス感染症治療市場規模・現状・予測(2021年-2027年) / Global Covid-19 Treatments Market Size, Status and Forecast 2021-2027 / QFJ1-4060資料のイメージです。• レポートコード:QFJ1-4060
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、87ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、新型コロナウイルス感染症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(錠剤、注射)、用途別市場規模(軽度症状患者、重篤症状患者)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・新型コロナウイルス感染症治療の市場動向
・企業の競争状況、市場シェア
・新型コロナウイルス感染症治療の種類別市場規模と予測2016-2027(錠剤、注射)
・新型コロナウイルス感染症治療の用途別市場規模と予測2016-2027(軽度症状患者、重篤症状患者)
・新型コロナウイルス感染症治療の北米市場規模2016-2027(アメリカ、カナダ)
・新型コロナウイルス感染症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・新型コロナウイルス感染症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・新型コロナウイルス感染症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・新型コロナウイルス感染症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Gilead Sciences、Merck、Eli Lilly and Company、Regeneron Pharmaceuticals)
・結論

Market Analysis and Insights: Global Covid-19 Treatments Market
The global Covid-19 Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Treatments market.

Global Covid-19 Treatments Scope and Market Size
Covid-19 Treatments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Covid-19 Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablet
Injection

Segment by Application
Mild Symptom Patient
Critically Ill Patient

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead Sciences
Merck
Eli Lilly and Company
Regeneron Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Covid-19 Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Covid-19 Treatments Market Perspective (2016-2027)
2.2 Covid-19 Treatments Growth Trends by Regions
2.2.1 Covid-19 Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Covid-19 Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Covid-19 Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Covid-19 Treatments Industry Dynamic
2.3.1 Covid-19 Treatments Market Trends
2.3.2 Covid-19 Treatments Market Drivers
2.3.3 Covid-19 Treatments Market Challenges
2.3.4 Covid-19 Treatments Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Treatments Players by Revenue
3.1.1 Global Top Covid-19 Treatments Players by Revenue (2016-2021)
3.1.2 Global Covid-19 Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Covid-19 Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Treatments Revenue
3.4 Global Covid-19 Treatments Market Concentration Ratio
3.4.1 Global Covid-19 Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Treatments Revenue in 2020
3.5 Covid-19 Treatments Key Players Head office and Area Served
3.6 Key Players Covid-19 Treatments Product Solution and Service
3.7 Date of Enter into Covid-19 Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Treatments Breakdown Data by Type
4.1 Global Covid-19 Treatments Historic Market Size by Type (2016-2021)
4.2 Global Covid-19 Treatments Forecasted Market Size by Type (2022-2027)

5 Covid-19 Treatments Breakdown Data by Application
5.1 Global Covid-19 Treatments Historic Market Size by Application (2016-2021)
5.2 Global Covid-19 Treatments Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Covid-19 Treatments Market Size (2016-2027)
6.2 North America Covid-19 Treatments Market Size by Type
6.2.1 North America Covid-19 Treatments Market Size by Type (2016-2021)
6.2.2 North America Covid-19 Treatments Market Size by Type (2022-2027)
6.2.3 North America Covid-19 Treatments Market Size by Type (2016-2027)
6.3 North America Covid-19 Treatments Market Size by Application
6.3.1 North America Covid-19 Treatments Market Size by Application (2016-2021)
6.3.2 North America Covid-19 Treatments Market Size by Application (2022-2027)
6.3.3 North America Covid-19 Treatments Market Size by Application (2016-2027)
6.4 North America Covid-19 Treatments Market Size by Country
6.4.1 North America Covid-19 Treatments Market Size by Country (2016-2021)
6.4.2 North America Covid-19 Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Covid-19 Treatments Market Size (2016-2027)
7.2 Europe Covid-19 Treatments Market Size by Type
7.2.1 Europe Covid-19 Treatments Market Size by Type (2016-2021)
7.2.2 Europe Covid-19 Treatments Market Size by Type (2022-2027)
7.2.3 Europe Covid-19 Treatments Market Size by Type (2016-2027)
7.3 Europe Covid-19 Treatments Market Size by Application
7.3.1 Europe Covid-19 Treatments Market Size by Application (2016-2021)
7.3.2 Europe Covid-19 Treatments Market Size by Application (2022-2027)
7.3.3 Europe Covid-19 Treatments Market Size by Application (2016-2027)
7.4 Europe Covid-19 Treatments Market Size by Country
7.4.1 Europe Covid-19 Treatments Market Size by Country (2016-2021)
7.4.2 Europe Covid-19 Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Treatments Market Size (2016-2027)
8.2 Asia-Pacific Covid-19 Treatments Market Size by Type
8.2.1 Asia-Pacific Covid-19 Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Covid-19 Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Covid-19 Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Covid-19 Treatments Market Size by Application
8.3.1 Asia-Pacific Covid-19 Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Covid-19 Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Covid-19 Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Covid-19 Treatments Market Size by Region
8.4.1 Asia-Pacific Covid-19 Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Covid-19 Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Covid-19 Treatments Market Size (2016-2027)
9.2 Latin America Covid-19 Treatments Market Size by Type
9.2.1 Latin America Covid-19 Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Covid-19 Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Covid-19 Treatments Market Size by Type (2016-2027)
9.3 Latin America Covid-19 Treatments Market Size by Application
9.3.1 Latin America Covid-19 Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Covid-19 Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Covid-19 Treatments Market Size by Application (2016-2027)
9.4 Latin America Covid-19 Treatments Market Size by Country
9.4.1 Latin America Covid-19 Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Covid-19 Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Treatments Market Size (2016-2027)
10.2 Middle East & Africa Covid-19 Treatments Market Size by Type
10.2.1 Middle East & Africa Covid-19 Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Covid-19 Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Covid-19 Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Covid-19 Treatments Market Size by Application
10.3.1 Middle East & Africa Covid-19 Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Covid-19 Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Covid-19 Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Covid-19 Treatments Market Size by Country
10.4.1 Middle East & Africa Covid-19 Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Covid-19 Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Covid-19 Treatments Introduction
11.1.4 Gilead Sciences Revenue in Covid-19 Treatments Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Covid-19 Treatments Introduction
11.2.4 Merck Revenue in Covid-19 Treatments Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Covid-19 Treatments Introduction
11.3.4 Eli Lilly and Company Revenue in Covid-19 Treatments Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Covid-19 Treatments Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Covid-19 Treatments Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Covid-19 Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Covid-19 Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Covid-19 Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Covid-19 Treatments Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Covid-19 Treatments Market Share by Regions (2016-2021)
Table 8. Global Covid-19 Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Covid-19 Treatments Market Share by Regions (2022-2027)
Table 10. Covid-19 Treatments Market Trends
Table 11. Covid-19 Treatments Market Drivers
Table 12. Covid-19 Treatments Market Challenges
Table 13. Covid-19 Treatments Market Restraints
Table 14. Global Covid-19 Treatments Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Covid-19 Treatments Market Share by Players (2016-2021)
Table 16. Global Top Covid-19 Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatments as of 2020)
Table 17. Ranking of Global Top Covid-19 Treatments Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Covid-19 Treatments Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Covid-19 Treatments Product Solution and Service
Table 21. Date of Enter into Covid-19 Treatments Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Covid-19 Treatments Revenue Market Share by Type (2016-2021)
Table 25. Global Covid-19 Treatments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Covid-19 Treatments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Covid-19 Treatments Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Covid-19 Treatments Revenue Market Share by Application (2016-2021)
Table 29. Global Covid-19 Treatments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Covid-19 Treatments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Covid-19 Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Covid-19 Treatments Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Covid-19 Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Covid-19 Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Covid-19 Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Covid-19 Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Covid-19 Treatments Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Covid-19 Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Covid-19 Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Covid-19 Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Covid-19 Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Covid-19 Treatments Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Covid-19 Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Covid-19 Treatments Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Covid-19 Treatments Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Covid-19 Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Covid-19 Treatments Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Covid-19 Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Covid-19 Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Covid-19 Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Covid-19 Treatments Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Covid-19 Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Covid-19 Treatments Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Covid-19 Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Covid-19 Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Covid-19 Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Covid-19 Treatments Product
Table 64. Gilead Sciences Revenue in Covid-19 Treatments Business (2016-2021) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Covid-19 Treatments Product
Table 69. Merck Revenue in Covid-19 Treatments Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Eli Lilly and Company Company Details
Table 72. Eli Lilly and Company Business Overview
Table 73. Eli Lilly and Company Covid-19 Treatments Product
Table 74. Eli Lilly and Company Revenue in Covid-19 Treatments Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly and Company Recent Development
Table 76. Regeneron Pharmaceuticals Company Details
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Covid-19 Treatments Product
Table 79. Regeneron Pharmaceuticals Revenue in Covid-19 Treatments Business (2016-2021) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Treatments Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Global Covid-19 Treatments Market Share by Application: 2020 VS 2027
Figure 5. Mild Symptom Patient Case Studies
Figure 6. Critically Ill Patient Case Studies
Figure 7. Covid-19 Treatments Report Years Considered
Figure 8. Global Covid-19 Treatments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Covid-19 Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Covid-19 Treatments Market Share by Regions: 2020 VS 2027
Figure 11. Global Covid-19 Treatments Market Share by Regions (2022-2027)
Figure 12. Global Covid-19 Treatments Market Share by Players in 2020
Figure 13. Global Top Covid-19 Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatments as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Covid-19 Treatments Revenue in 2020
Figure 15. Global Covid-19 Treatments Revenue Market Share by Type (2016-2021)
Figure 16. Global Covid-19 Treatments Revenue Market Share by Type (2022-2027)
Figure 17. North America Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Covid-19 Treatments Market Share by Type (2016-2027)
Figure 19. North America Covid-19 Treatments Market Share by Application (2016-2027)
Figure 20. North America Covid-19 Treatments Market Share by Country (2016-2027)
Figure 21. United States Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Covid-19 Treatments Market Share by Type (2016-2027)
Figure 25. Europe Covid-19 Treatments Market Share by Application (2016-2027)
Figure 26. Europe Covid-19 Treatments Market Share by Country (2016-2027)
Figure 27. Germany Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Covid-19 Treatments Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Covid-19 Treatments Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Covid-19 Treatments Market Share by Region (2016-2027)
Figure 37. China Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Covid-19 Treatments Market Share by Type (2016-2027)
Figure 45. Latin America Covid-19 Treatments Market Share by Application (2016-2027)
Figure 46. Latin America Covid-19 Treatments Market Share by Country (2016-2027)
Figure 47. Mexico Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Covid-19 Treatments Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Covid-19 Treatments Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Covid-19 Treatments Market Share by Country (2016-2027)
Figure 53. Turkey Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Covid-19 Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Gilead Sciences Revenue Growth Rate in Covid-19 Treatments Business (2016-2021)
Figure 57. Merck Revenue Growth Rate in Covid-19 Treatments Business (2016-2021)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Covid-19 Treatments Business (2016-2021)
Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Treatments Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed